The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mckesson Ventures, Llc since 2020.
This trader's CIK number is 1827312.
At the time of last reporting, Mckesson Ventures, Llc was the 10% Owner of Augmedix, Inc.. (stock ticker symbol AUGX).
Also see all insider trading activities at Augmedix, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | AUGX | 0 | $0 | 100,365 | $158,086 | 0 | $0 |
| 2021 | AUGX | 87,500 | $350,000 | 0 | $0 | 0 | $0 |
| 2020 | AUGX | 666,666 | $1,999,998 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-10-03 | AUGX | Sale | 1,779 | 1.41 | 2,508 |
| 2022-09-30 | AUGX | Sale | 12,194 | 1.46 | 17,803 |
| 2022-10-03 | AUGX | Sale | 1,779 | 1.41 | 2,508 |
| 2022-09-30 | AUGX | Sale | 12,194 | 1.46 | 17,803 |
| 2022-10-03 | AUGX | Sale | 1,779 | 1.41 | 2,508 |
| 2022-09-30 | AUGX | Sale | 12,194 | 1.46 | 17,803 |
| 2022-09-28 | AUGX | Sale | 1,000 | 1.50 | 1,500 |
| 2022-09-29 | AUGX | Sale | 8,997 | 1.48 | 13,315 |
| 2022-09-26 | AUGX | Sale | 2,300 | 1.56 | 3,588 |
| 2022-09-27 | AUGX | Sale | 7,337 | 1.68 | 12,326 |
| 2022-09-22 | AUGX | Sale | 3,733 | 1.77 | 6,607 |
| 2022-09-23 | AUGX | Sale | 12,113 | 1.58 | 19,138 |
| 2022-09-22 | AUGX | Sale | 3,733 | 1.77 | 6,607 |
| 2022-09-23 | AUGX | Sale | 12,113 | 1.58 | 19,138 |
| 2022-09-19 | AUGX | Sale | 3,900 | 2.18 | 8,502 |
| 2022-09-20 | AUGX | Sale | 2,500 | 2.02 | 5,050 |
| 2022-09-21 | AUGX | Sale | 720 | 1.92 | 1,382 |
| 2021-10-28 | AUGX | Buy | 87,500 | 4.00 | 350,000 |
| 2020-10-05 | NONE | Buy | 666,666 | 3.00 | 1,999,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckesson Ventures, Llc (10% Owner of Augmedix, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.